Loading organizations...
§ Venture Capital · San Francisco, CA, USA
early-stage venture capital firm investing in B2B software startups, providing capital and operational support for pre-seed and seed stages.
Key people at Coughdrop Capital.
Coughdrop Capital is an early-stage venture capital firm based in San Francisco and Los Angeles, California, that invests in pre-seed and seed-stage B2B software startups. The firm operates as a dedicated first-check investor, writing initial checks ranging from $40,000 to $500,000 to support emerging enterprise, consumer, and financial technology sector companies. Operating with a small team of two core partners, the firm provides hands-on operational support in sales, product development, and go-to-market strategies, and can finalize investment decisions within 24 hours of meeting founders. Coughdrop Capital has backed notable portfolio companies such as Superhuman and Lattice, while its early investments frequently attract follow-on capital from prominent venture firms including Khosla Ventures, Founders Fund, and Andreessen Horowitz. The venture capital organization was originally established in Bend, Oregon, in 2015 by founding brothers Austin Petersmith and Stu Smith.
Key people at Coughdrop Capital.
Coughdrop Capital is an early-stage venture firm known for its founder-first approach and rapid decision-making, investing in ambitious founders building technology-driven startups. The firm’s mission centers on empowering smart entrepreneurs at the earliest stages—often pre-seed or seed—with not just capital, but hands-on operational support and deep founder empathy. Coughdrop Capital’s investment philosophy emphasizes speed, founder alignment, and long-term partnership, making it a preferred choice for founders who value both strategic guidance and operational experience.
The firm primarily backs B2B software startups, with a strong focus on sectors like SaaS, fintech, cybersecurity, and enterprise technology. By investing early and staying deeply involved, Coughdrop Capital has played a pivotal role in shaping the growth trajectories of several breakout startups, contributing to the broader momentum in the early-stage tech ecosystem.
---
Founded in 2015 by brothers Austin Petersmith and Stu Smith, Coughdrop Capital emerged from their shared experience as both founders and investors. The duo’s journey began in Bend, Oregon, but the firm has since expanded its footprint to San Francisco and Los Angeles, reflecting its growing influence in the tech investment landscape. Austin and Stu bring a rare blend of operational expertise and investor insight, having navigated the challenges of building and scaling startups themselves.
Their evolution from local investors to a nationally recognized micro-fund was fueled by a commitment to speed and founder support. Coughdrop Capital quickly distinguished itself by making investment decisions within 24 hours of meeting founders—a practice that resonated with time-constrained entrepreneurs. Over the years, the firm has cultivated a reputation for being more than just a source of capital, becoming a trusted partner for founders navigating the complexities of early-stage growth.
---
---
Coughdrop Capital is riding the wave of the micro-fund revolution, where small, agile funds are increasingly shaping the early-stage ecosystem. The firm’s focus on B2B software and fintech aligns with broader trends in enterprise digitization, remote work, and financial innovation. By investing early and providing operational support, Coughdrop Capital helps founders navigate the critical transition from idea to product-market fit, accelerating the pace of innovation in key sectors.
Their success also reflects a shift in how founders choose investors—not just for capital, but for strategic partnership and operational expertise. As the startup ecosystem becomes more competitive, Coughdrop Capital’s model of speed, founder empathy, and hands-on involvement is setting a new standard for what founders expect from early-stage investors.
---
Coughdrop Capital is poised to continue its influence in the early-stage tech ecosystem, particularly as demand for founder-friendly, operationally savvy investors grows. The firm’s ability to move quickly and provide meaningful support will remain a key advantage in an increasingly crowded market. As new trends in AI, fintech, and enterprise software continue to emerge, Coughdrop Capital is well-positioned to back the next generation of breakout startups.
Looking ahead, the firm’s focus on founder relationships and operational excellence will likely shape the evolution of micro-funds and early-stage investing. Coughdrop Capital’s journey—from a small, founder-driven fund to a nationally recognized player—demonstrates the power of empathy, speed, and deep operational insight in building generational companies.
Coughdrop Capital has more than 26 tracked investments across 22 companies. The latest tracked deal is $23.0M Series A in Hello Patient in September 2025.
